Patch Testing Identifies Allergens Responsible for Contact Dermatitis Patch Testing Identifies Allergens Responsible for Contact Dermatitis
Patch testing is useful for identifying allergens responsible for facial dermatitis in male patients and for anogenital dermatitis, according to two analyses of data from the North American Contact Dermatitis Group (NACDG).Reuters Health Information
CONCLUSIONS: All patients with a suspected contact allergy should receive a guideline-based patch test at an early stage. Targeted patch testing identifies clinically relevant allergens and provides suggestions for further systematic investigations. PMID: 31950209 [PubMed - as supplied by publisher]
Cyanoacrylate-based adhesives are commonly used in wound closure, but cases of contact dermatitis associated with the use of these products have been reported.Plastic and Reconstructive Surgery
ConclusionsGeneral-population infants introduced to peanut after age 12 months were more likely to have sensitization and probable clinical allergy to peanut at 3 years.
This is the first study that objectively compares the molecular cutaneous improvement with different treatments in AD and may facilitate personalized medicine by identifying the best treatments for individual phenotypes, based on immune/barrier profiles.
Authors: Rodrigues MA, Torres T PMID: 31933476 [PubMed - in process]
Condition: Atopic Dermatitis Interventions: Device: GPSkin Barrier Pro; Device: Aquaflux AF200 Sponsors: Northwestern University; National Jewish Health; National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
ConclusionsThe prevalence of p-phenylenediamine allergy remains high among patients with contact eczema. Risk factors for p-phenylenediamine contact allergy are consistent with previous reports.ResumenAntecedentes y objetivosEl objetivo del trabajo es mostrar la tendencia de la sensibilización de contacto entre los años 2004-2014 tras la regulación de su concentración en cosméticos en el año 2009 e investigar los factores de riesgo de la alergia de contacto a la parafenilendiamina.Material y métodosEl diseño del estudio fue observacional retrospectivo incluyendo pacie...
Our results demonstrate that IL-32 γ can suppress the development of atopic dermatitis by prevention of pro-inflammatory cytokine release through inhibition of NF-κB-mediated miR-205 expression. IL-32γ could be useful for treatment of atopic dermatitis.
PMID: 31923547 [PubMed - as supplied by publisher]
Atopic dermatitis (AD) impacts up to 20% of children worldwide (1;2). Children with AD experience physical discomfort, poorer quality of life (3-5), increased behavior problems (6;7), higher frequency of attention-deficit/hyperactivity disorder (ADHD) (8-11) and higher healthcare utilization (12). Parents of children with AD report decreased quality of life (13-16), negative impact on the family (14;17), increased depression and anxiety (16), and increased work absenteeism (18;19).